| scholarly article | Q13442814 |
| P2093 | author name string | Stephen C Pflugfelder | |
| Gary N Foulks | |||
| P2860 | cites work | Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 |
| In-depth analysis of the human tear proteome | Q28267473 | ||
| Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. | Q31775977 | ||
| Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease | Q33869200 | ||
| Tear osmolarity variation in the dry eye. | Q34164990 | ||
| Human tear protein analysis enabled by an alkaline microfluidic homogeneous immunoassay | Q34215552 | ||
| Abnormal protein profiles in tears with dry eye syndrome | Q34218114 | ||
| Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. | Q34544207 | ||
| Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients | Q34646765 | ||
| Reflective meniscometry: a non-invasive method to measure tear meniscus curvature | Q35306915 | ||
| Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye | Q35560971 | ||
| Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome | Q35674608 | ||
| A rapid standardized quantitative microfluidic system approach for evaluating human tear proteins. | Q36350426 | ||
| Investigation of the human tear film proteome using multiple proteomic approaches | Q36499336 | ||
| Autoimmunity at the ocular surface: pathogenesis and regulation | Q36625074 | ||
| Tear cytokine profiles in dysfunctional tear syndrome. | Q36637791 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome | Q36676823 | ||
| Correlations among upper and lower tear menisci, noninvasive tear break-up time, and the Schirmer test | Q36681148 | ||
| Factors predicting the ocular surface response to desiccating environmental stress | Q36827562 | ||
| Concept of functional visual acuity and its applications | Q36946438 | ||
| The Ocular Protection Index | Q37180354 | ||
| Compositional profiling and biomarker identification of the tear film. | Q37283520 | ||
| The importance of the precorneal tear film for the quality of optical imaging | Q37295478 | ||
| What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? | Q37397203 | ||
| Predicted phenotypes of dry eye: proposed consequences of its natural history. | Q37453768 | ||
| Proteomics in ocular fluids | Q37817122 | ||
| Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. | Q42173370 | ||
| Tear osmolarity as a biomarker for dry eye disease severity | Q43099149 | ||
| The role of oxidative stress and inflammation in conjunctivochalasis | Q43216667 | ||
| Assessment of tear film stability in dry eye with a newly developed keratograph | Q44378501 | ||
| Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. | Q44757521 | ||
| Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease | Q45229126 | ||
| Contrast sensitivity and tear layer aberrometry in dry eye patients. | Q46003492 | ||
| Efficacy of punctum plug treatment in short break-up time dry eye. | Q46447852 | ||
| In situ osmometry: validation and effect of sample collection technique. | Q46910273 | ||
| Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease | Q47425157 | ||
| Corneal fluorescein staining correlates with visual function in dry eye patients | Q48211343 | ||
| An objective approach to dry eye disease severity | Q48343172 | ||
| Proceedings: The lysozyme agar diffusion test in the sicca syndrome. | Q53789867 | ||
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Association of tear proteins with Meibomian gland disease and dry eye symptoms | Q56775803 | ||
| Identification of Tear Fluid Biomarkers in Dry Eye Syndrome Using iTRAQ Quantitative Proteomics | Q56775850 | ||
| Inflammatory Markers in the Tears of Patients with Ocular Surface Disease | Q58979336 | ||
| Evaluation of a New Tear Osmometer for Repeatability and Accuracy, Using 0.5-μL (500-Nanoliter) Samples | Q61759594 | ||
| Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production | Q61851319 | ||
| Tear Osmolarity and Ocular Surface Disease in Keratoconjunctivitis Sicca | Q66920601 | ||
| A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, and tear osmolarity | Q67294303 | ||
| Osmolarity of Tear Microvolumes in Keratoconjunctivitis Sicca | Q67324592 | ||
| Non-invasive tear film break-up time: sensitivity and specificity | Q69653231 | ||
| Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea | Q73049032 | ||
| The pathology of dry eye: the interaction between the ocular surface and lacrimal glands | Q77575256 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome | Q77846439 | ||
| Tear film osmolarity: determination of a referent for dry eye diagnosis | Q79143768 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study | Q83540737 | ||
| Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management | Q83809653 | ||
| The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients | Q84087842 | ||
| Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays | Q84579952 | ||
| Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial | Q85632111 | ||
| Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography | Q87410340 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1122-1129 | |
| P577 | publication date | 2014-03-12 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | New testing options for diagnosing and grading dry eye disease | |
| P478 | volume | 157 |
| Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
| Q35786703 | Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye. |
| Q39987388 | Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement? |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q55112422 | Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. |
| Q39816145 | Evaluating the Functionality of Conjunctiva Using a Rabbit Dry Eye Model. |
| Q86505040 | Non-invasive estimation of hydration status changes through tear fluid osmolarity during exercise and post-exercise rehydration |
| Q42126622 | Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model |
Search more.